The estimated Net Worth of Renato Tamaro is at least $1.9 Миллион dollars as of 16 May 2024. Renato Tamaro owns over 1,154 units of Steris Plc stock worth over $1,895,572 and over the last 6 years he sold STE stock worth over $0. In addition, he makes $0 as Vice President and Corporate Treasurer at Steris Plc.
Renato has made over 3 trades of the Steris Plc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 1,154 units of STE stock worth $131,810 on 16 May 2024.
The largest trade he's ever made was exercising 2,065 units of Steris Plc stock on 14 August 2019 worth over $175,979. On average, Renato trades about 246 units every 91 days since 2018. As of 16 May 2024 he still owns at least 7,831 units of Steris Plc stock.
You can see the complete history of Renato Tamaro stock trades at the bottom of the page.
Renato Tamaro is the Vice President and Corporate Treasurer at Steris Plc.
Renato Tamaro is 51, he's been the Vice President and Corporate Treasurer of Steris Plc since 2017. There are 15 older and 5 younger executives at Steris Plc. The oldest executive at Steris Plc is David Lewis, 76, who is the Independent Director.
Renato's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough и John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: